Physicochemical Characterization and Stability of Rifampicin Liposome Dry Powder Formulations for Inhalation
- 1 February 2009
- journal article
- Published by Elsevier BV in Journal of Pharmaceutical Sciences
- Vol. 98 (2), 628-639
- https://doi.org/10.1002/jps.21441
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Liposome Technology for Drug Delivery Against Mycobacterial InfectionsCurrent Pharmaceutical Design, 2004
- Design of liposomal aerosols for improved delivery of rifampicin to alveolar macrophagesInternational Journal of Pharmaceutics, 2003
- Chemotherapeutic activity against murine tuberculosis of once weekly administered drugs (isoniazid and rifampicin) encapsulated in liposomesInternational Journal of Antimicrobial Agents, 2002
- Novel applications of liposomesTrends in Biotechnology, 1998
- Therapeutic efficacies of isoniazid and rifampin encapsulated in lung-specific stealth liposomes against Mycobacterium tuberculosis infection induced in miceAntimicrobial Agents and Chemotherapy, 1997
- Lung specific stealth liposomes: stability, biodistribution and toxicity of liposomal antitubercular drugs in miceBiochimica et Biophysica Acta (BBA) - General Subjects, 1997
- In vitro activities of free and liposomal drugs against Mycobacterium avium-M. intracellulare complex and M. tuberculosisAntimicrobial Agents and Chemotherapy, 1993
- Liposomes and Nanoparticles in the Treatment of Intracellular Bacterial InfectionsPharmaceutical Research, 1991
- RifampinAnalytical Profiles of Drug Substances, 1976
- Diffusion of univalent ions across the lamellae of swollen phospholipidsJournal of Molecular Biology, 1965